CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19
Clinical trial NCT04516941 · TERMINATED
Trial details
- NCT number
- NCT04516941
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-21
- Primary completion
- 2022-08-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.